Beleggen.nl Markt MonitorMarkt Monitor

Amerikaanse aandelen Terug naar discussie overzicht

POET Technologies Inc.

3.208 Posts
Pagina: «« 1 ... 39 40 41 42 43 ... 161 »» | Laatste | Omlaag ↓
  1. [verwijderd] 15 april 2014 21:01
    LMAO ;-)

    Nu terug op 2.37 & L2 ziet er behoorlijk goed uit dus we kunnen best in de 2.40+ eindigen.

    V:PTK Depth by Price @14:59:19
    Bid Ask
    Orders Size Price Price Size Orders
    3 6,000 2.37 2.38 10,000 1
    5 19,490 2.36 2.39 1,000 1
    6 50,635 2.35 2.40 10,000 4
    5 12,000 2.34 2.41 1,000 1
    3 5,000 2.33 2.42 10,000 1
  2. nobahamas 15 april 2014 22:07
    Wederom de twijvelaars verlost van een ondergewaardeerd belang.
    Dik tweemaal de dagomzet en verder stijgen (nu 2,43)!!
  3. [verwijderd] 16 april 2014 01:07
    jongens en meisjes
    Dit is echt mooi
    Ik zit er ook dik in
    Dit is gaaf!!!
    Genieten maar
    en stel......dat Poet eens een klapje krijgt dan heb je nog genoeg!
  4. [verwijderd] 16 april 2014 01:11
    ik wil graag bijkopen maar durven? Ik pluk wel graag de mooiste bloemetjes aan de rand van de afgrond. Maar dit is niet eens de rand van een afgrond, want het lijdt nog niet onder winstnemingen.
  5. [verwijderd] 16 april 2014 02:07
    What's happening with POET? Why the four-bag gain in under three months? Does POET cure cancer or something?

    Well, as long-time MTA readers know, POET stands for "Planar Opto-Electronic Technology." That is, POET is an entirely new platform for "monolithic" fabrication of integrated circuit devices -- one chip, period -- containing both electronic and optical elements all on a single semiconductor wafer.

    What does that mean in plain English (at least "plainer" English)? Think of complex electronic systems. They're made up of different kinds of circuits, all wired and soldered together, sucking power, requiring cooling and taking time to communicate with each other. Except now with POET you can combine multiple tasks onto one low-powered chip. Much of the heavy lifting in terms of signal processing is done with coherent photons, better known as lasers -- nanolasers, actually. As in... nano-lasers are that "planar opto-electronic" part of the system, hence the name POET.

    With POET, designers and engineers can build faster, more efficient semiconductor devices of any kind, beyond electronics, beyond optics and beyond silicon.

    Let's get back to military apps for a moment. POET started, some years back, as a sort of "solar power" idea. Take photons, absorb them onto nano-scale, gallium-arsenide transceivers on a chip and convert them into electricity. Except that Dr. Taylor and colleagues reversed the process, such that you can now put electricity into the transceivers, and get "aimed" laser light out. If you ever watched Star Trek, it's sort of like the "phaser" guns on the USS Enterprise.

    Amending Moore's Law

    Still scratching your head? Well, that's OK; it IS highly technical, and it helps to be kind of geeky, if not learned in solid state physics and quantum chemistry.

    Let's approach it another way. Recall Moore's law, which is that computing power doubles every 18 months or so. This has been the case for nearly 50 years, based on silicon. It's why you have iPads instead of big, clunky desktops; or flat-screen TVs, instead of big old tube sets; or an iPhone instead of an old "brick" telephone.

    It's all good, right? Except that Moore's law is rapidly becoming outdated, based on the fact that silicon is approaching fundamental atomic limits for pushing electrons around. You can only make silicon chips only so small. Then the electrons start bumping into each other, so to speak.

    Now along comes POET and its photons. The quantum physics are different, as compared with silicon. With POET, things operate at smaller scale, and much faster, with less power usage. Thus, overall, POET adds several more years to Moore's law. More doubling for a few more generations.

    I hate to use buzzwords, but... POET is transformational. It's historic -- seriously. You are watching fundamental change if you follow POET. It's "breakthrough" tech, even though the guy who's been pioneering the idea (Dr. Geoffrey Taylor, now of University of Connecticut at Storrs) has been toiling at his workbench for nearly 40 years, going back to his days at old AT&T and Bell Labs.

    What's Driving the Share Price?

    OK, so POET is totally cool physics, it's 40 years in development, it's Star Trek in the here and now, and the share price languished in much of 2013. Why is it hot? Why the recent share price rise?

    Because a few weeks ago, POET announced the release of a POET Technology Design Kit Documentation (POET/TDK). It's the basic technical documentation that electronics industry geeks need to begin incorporating the tech into working systems from computers to hand-held devices to televisions to radars and much, much more.

    In essence, POET/TDK provides documentation for the entire catalog of active electronic and electro-optical devices currently supported by POET processes. Specifically, POET/DTK offers a comprehensive device parameter library. It enables potential customers and partners -- like semiconductor foundries (Intel, AMD, Taiwan Semiconductor, et al.) and device and library developers (Apple, Samsung, et al.) -- to implement the POET process.

    At root, this is where the money is. Down at the firehall, it's time for some little old lady to yell, "BINGO!"

    The Coming POET Ecosystem

    As usage grows, POET/TDK will become the foundation for licensed designs within a POET ecosystem. The tech will proliferate across the electronics industry and work its way into complementary metal-oxide semiconductor (CMOS) functions as designers optimize POET and migrate it into their work efforts.

    Completing the POET/TDK release marks a critical step to commercializing the tech and thus, to monetizing POET intellectual property. Now, potential customers can apply POET in a context that's specific to their own design and manufacturing framework.

    Meanwhile, POET's chief scientist, Dr. Geoffrey Taylor, will give a major talk at the Empire Club of Canada on April 28, 2014. The program is sponsored by Canada's National Post newspaper and should garner global levels of attention. Dr. Taylor will spotlight POET's semiconductor solution in the race to sustain Moore's law beyond the constraints of traditional silicon.

    So between the new design kit and Dr. Taylor's forthcoming speech to a global audience, I expect the POET buzz to build.

    Outlook

    Based on several reader emails, I detect that some of you are getting nervous. What goes up must come down, right? Should you sell some shares, if you're a holder? I've had emails from readers along these lines asking what to do. Should you sell enough to recover principal? Take some money off the table? Book a gain?

    In general, I'm never against recovering principal and booking gains. Rule No. 1 of investing is, "I want my money back."

    Still, I believe there's much further to go with POET. So no, I'm NOT recommending that you sell anything.

    Of course, every subscriber has to make his/her own decision. If you need cash -- to pay taxes, tuitions, bills, etc. -- you should do what you need to do. Otherwise, I believe that POET is on a roll and we have big things yet to come.

    Remember though, this is still a pre-operational, -pre-revenue company — POET could join the rest of the tech sector and pull back. But the promise is there. This one looks like it's really going places. And since it's a truly small play, even smallish price moves can drive the share price to more multiples.

    If you don't own shares? Are you just out in the cold? Well, again, I like the company and where it's going. Obviously, if you jump in now, you're buying on the upside of a momentum play. Then again, I believe the momentum is still there. We might see some strong upswings, as well as some down days, too. In general, I'm okay with at least starting a shareholding position, as long as you accept the risk that another tech down-draft might hit.

    Bottom line? I like POET. I've visited the lab at Storrs. I've met the people. I'm closely following the company. The tech will change the world, in many ways. It's all good.

    That's all for now. Thanks for subscribing to MTA.

    Best wishes...

    Byron W. King
3.208 Posts
Pagina: «« 1 ... 39 40 41 42 43 ... 161 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beleggen.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.102
AB InBev 2 5.529
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.951
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.807
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.782
Aedifica 3 925
Aegon 3.258 323.007
AFC Ajax 538 7.088
Affimed NV 2 6.303
ageas 5.844 109.897
Agfa-Gevaert 14 2.062
Ahold 3.538 74.345
Air France - KLM 1.025 35.250
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.048
Alfen 16 25.107
Allfunds Group 4 1.514
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 409
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.638
AMG 971 134.102
AMS 3 73
Amsterdam Commodities 305 6.740
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.031
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.789
Arcelor Mittal 2.034 320.895
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.342
Aroundtown SA 1 221
Arrowhead Research 5 9.750
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.564
ASML 1.766 109.563
ASR Nederland 21 4.506
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.735
Axsome Therapeutics 1 177
Azelis Group 1 66
Azerion 7 3.439